These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 743386)

  • 21. Pharmacokinetics of Cytembena in chronic renal impairment.
    Schück O; Grafnetterová J; Sotorník I
    Neoplasma; 1976; 23(2):161-70. PubMed ID: 947088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal and adrenal function following acute administration of urapidil in hypertensive patients with normal and impaired renal function].
    Wambach G; Godehardt E; Lang R; Haerlin R; Meurer KA
    Arzneimittelforschung; 1987 Aug; 37(8):960-4. PubMed ID: 3675693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of dysphosphoremia in patients admitted in intensive care unit with an impaired renal function].
    Joly LM; Troché G; Trouiller P; Boukhalil M; Zazzo JF
    Ann Fr Anesth Reanim; 2005 Jul; 24(7):791-4. PubMed ID: 15925478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum lipoprotein abnormalities in renal diseases - a comparative study with histopathological diagnosis (author's transl)].
    Handa Y; Ishida K; Ikezono T; Hesaka K; Ohta N; Takeda I; Shibata M
    Rinsho Byori; 1981 Aug; 29(8):839-44. PubMed ID: 7311046
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum amylase in patients with renal insufficiency and renal failure.
    Collen MJ; Ansher AF; Chapman AB; Mackow RC; Lewis JH
    Am J Gastroenterol; 1990 Oct; 85(10):1377-80. PubMed ID: 1699413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics and metabolism of trazodone in man (author's transl)].
    Jauch R; Kopitar Z; Prox A; Zimmer A
    Arzneimittelforschung; 1976; 26(11):2084-9. PubMed ID: 1037253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPLC of trazodone in serum after microscale protein precipitation.
    Lam S; Boselli L
    Biomed Chromatogr; 1986 Aug; 1(4):177-9. PubMed ID: 3506832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of anticholinergic side effects with a new antidepressent--trazodone.
    Gershon S; Newton R
    J Clin Psychiatry; 1980 Mar; 41(3):100-4. PubMed ID: 7354015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative double-blind study on efficacy and side-effects of trazodone, nomifensine, mianserin in elderly patients.
    Scardigli G; Jans G
    Adv Biochem Psychopharmacol; 1982; 32():229-36. PubMed ID: 7046366
    [No Abstract]   [Full Text] [Related]  

  • 30. Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography.
    Miller RL; DeVane CL
    J Chromatogr; 1986 Jan; 374(2):388-93. PubMed ID: 3958096
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of renal function from the blood urea and serum creatinine concentrations.
    Wing AJ
    East Afr Med J; 1969 May; 46(5):329-33. PubMed ID: 5345971
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers.
    Lawlor BA; Radcliffe J; Martinez R; Sunderland T; Murphy DL
    Biol Psychiatry; 1997 Mar; 41(6):756-7. PubMed ID: 9067003
    [No Abstract]   [Full Text] [Related]  

  • 33. Trazodone overdose: report of two cases.
    Root I; Ohlson GB
    J Anal Toxicol; 1984; 8(2):91-4. PubMed ID: 6716980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid atrial fibrillation associated with trazodone hydrochloride.
    White WB; Wong SH
    Arch Gen Psychiatry; 1985 Apr; 42(4):424. PubMed ID: 3977562
    [No Abstract]   [Full Text] [Related]  

  • 35. Variations in plasma drug levels from different laboratories.
    Rathbun JM; Bentz N
    Am J Psychiatry; 1986 Sep; 143(9):1196. PubMed ID: 3752310
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 3 Single Doses of Trazodone on QTc Interval in Healthy Subjects.
    Tellone V; Rosignoli MT; Picollo R; Dragone P; Del Vecchio A; Comandini A; Radicioni M; Leuratti C; Calisti F
    J Clin Pharmacol; 2020 Nov; 60(11):1483-1495. PubMed ID: 32488885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of antidepressants in patients with hepatic impairment.
    Mauri MC; Fiorentini A; Paletta S; Altamura AC
    Clin Pharmacokinet; 2014 Dec; 53(12):1069-81. PubMed ID: 25248846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rediscovering trazodone for the treatment of major depressive disorder.
    Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
    CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability of trazodone formulations using stable isotope methodology.
    Gammans RE; Mackenthun AV; Russell JW
    Br J Clin Pharmacol; 1984 Sep; 18(3):431-7. PubMed ID: 6487481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of trazodone serum concentrations in patients with normal or impaired renal function.
    Catanese B; Dionisio A; Barillari G; De Martino C
    Boll Chim Farm; 1978 Jul; 117(7):424-7. PubMed ID: 743386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.